Brief: Alkermes Announces Four Abstracts Accepted For Presentation At The 2022 American Society Of Clinical Oncology (Asco) Annual Meeting
09/05/2022 12:30
May 9 (Reuters) - Alkermes Plc ALKS.O :
* ALKERMES ANNOUNCES FOUR ABSTRACTS ACCEPTED FOR
PRESENTATION AT
THE 2022 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL
MEETING
Source text for Eikon: ID:nPnc9LYpWa
Further company coverage: ALKS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkermes
See all newsBrief: Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study Of Alixorexton In Adults With Narcolepsy Type 2 At Sleep 2026
Brief: Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz
Brief: Alkermes Announces Effectiveness Of Mural Oncology Form 10 Registration Statement
Alkermes Plc reports results for the quarter ended in September - Earnings Summary
Brief: Alkermes Q3 Net Income USD 47.8 Million